PRESS RELEASE published on 02/25/2025 at 22:01, 11 months 4 days ago DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates DBV Technologies Epicutaneous Immunotherapy Viaskin Peanut Patch AAAAI/WAO Joint Congress PEPITES Study
BRIEF published on 01/13/2025 at 22:10, 1 year ago DBV Technologies Half-Yearly Liquidity Statement Liquidity Contract ODDO BHF Stock Market Transactions DBV Technologies VIASKIN®
PRESS RELEASE published on 01/13/2025 at 22:05, 1 year ago Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies issues Half-Year Report on liquidity contract with ODDO BHF, revealing assets in the account and transaction details Liquidity Contract Half-year Report Biopharmaceutical Company ODDO BHF DBV Technologies
BRIEF published on 12/02/2024 at 22:35, 1 year 1 month ago DBV Technologies: Voting rights and shares as of November 30, 2024 Share Capital Voting Rights Actions DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 12/02/2024 at 22:30, 1 year 1 month ago Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 Company provides update on total voting rights and shares as of November 30, 2024 in compliance with AMF regulations Shares Total Voting Rights AMF Regulations NYSE Euronext Paris November 30 2024
BRIEF published on 11/20/2024 at 15:33, 1 year 2 months ago Braidwell LP Crosses Thresholds at DBV Technologies Actions Investment Crossing Thresholds DBV Technologies Braidwell LP
BRIEF published on 11/06/2024 at 22:35, 1 year 2 months ago DBV Technologies Facing Financial Uncertainties in Q3 2024 Financial Results Cash Flow Net Loss Q3 2024 DBV Technologies
PRESS RELEASE published on 11/06/2024 at 22:30, 1 year 2 months ago DBV Technologies Reports Third Quarter 2024 Financial Results DBV Technologies reports Q3 2024 financial results, with $46.4 million cash balance. Approves quarterly financial statements. Faces challenges in securing future financing Financial Results Financing Clinical Trials Cash Balance DBV Technologies
BRIEF published on 10/31/2024 at 09:05, 1 year 2 months ago Braidwell LP Crosses Thresholds in DBV Technologies Warrants Actions DBV Technologies Participation Threshold Braidwell LP
BRIEF published on 10/22/2024 at 22:50, 1 year 3 months ago DBV's Viaskin Peanut Patch Secures Regulatory Progress in US and EU FDA Approval DBV Technologies Viaskin Peanut Regulatory Update EMA Guidance
Published on 01/30/2026 at 02:15, 4 hours 19 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 6 hours 34 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 7 hours 34 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 11 hours 49 minutes ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 12 hours 34 minutes ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/30/2026 at 04:30, 2 hours 4 minutes ago A First Look at AI in the Real World: AWE 2026 Opens This March in Shanghai
Published on 01/30/2026 at 03:35, 2 hours 59 minutes ago Bybit Unveils 2026 Vision as "The New Financial Platform," Expanding Beyond Exchange Into Global Financial Infrastructure
Published on 01/30/2026 at 00:07, 6 hours 26 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 9 hours 31 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 9 hours 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 18:00, 12 hours 34 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 12 hours 49 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 12 hours 49 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 10:07, 20 hours 26 minutes ago Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech
